ロード中...
Late erythropoiesis‐stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants
BACKGROUND: Preterm infants have low plasma levels of erythropoietin (EPO), providing a rationale for the use of erythropoiesis‐stimulating agents (ESAs) to prevent or treat anaemia. Darbepoetin (Darbe) and EPO are currently available ESAs. OBJECTIVES: To assess the effectiveness and safety of late...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6378929/ https://ncbi.nlm.nih.gov/pubmed/30776084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004868.pub5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|